- Home
- ESTA vs SANA Comparison
ESTA vs SANA Comparison
Compare ESTA & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESTA
- SANA
- Stock Information
- Founded
- ESTA 2004
- SANA 2018
- Country
- ESTA Costa Rica
- SANA United States
- Employees
- ESTA N/A
- SANA N/A
- Industry
- ESTA Industrial Specialties
- SANA Medicinal Chemicals and Botanical Products
- Sector
- ESTA Health Care
- SANA Health Care
- Exchange
- ESTA Nasdaq
- SANA Nasdaq
- Market Cap
- ESTA 1.1B
- SANA 983.4M
- IPO Year
- ESTA 2018
- SANA 2021
- Fundamental
- Price
- ESTA $40.07
- SANA $4.12
- Analyst Decision
- ESTA Strong Buy
- SANA Strong Buy
- Analyst Count
- ESTA 6
- SANA 6
- Target Price
- ESTA $57.00
- SANA $8.00
- AVG Volume (30 Days)
- ESTA 280.6K
- SANA 3.8M
- Earning Date
- ESTA 11-06-2025
- SANA 11-07-2025
- Dividend Yield
- ESTA N/A
- SANA N/A
- EPS Growth
- ESTA N/A
- SANA N/A
- EPS
- ESTA N/A
- SANA N/A
- Revenue
- ESTA $177,418,000.00
- SANA N/A
- Revenue This Year
- ESTA $28.32
- SANA N/A
- Revenue Next Year
- ESTA $24.16
- SANA N/A
- P/E Ratio
- ESTA N/A
- SANA N/A
- Revenue Growth
- ESTA 17.22
- SANA N/A
- 52 Week Low
- ESTA $26.56
- SANA $1.26
- 52 Week High
- ESTA $50.85
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- ESTA 49.51
- SANA 68.83
- Support Level
- ESTA $38.50
- SANA $3.28
- Resistance Level
- ESTA $42.73
- SANA $3.58
- Average True Range (ATR)
- ESTA 2.28
- SANA 0.23
- MACD
- ESTA -0.00
- SANA 0.11
- Stochastic Oscillator
- ESTA 47.30
- SANA 90.98
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.